A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
Clinical trial NCT04784897 · COMPLETED
Trial details
- NCT number
- NCT04784897
- Sponsor
- Innovation Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-07-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.